Monday, May 10, 2021

EU: Pandemic measures to total about $5.85 trillion


FILE - In this Wednesday, April 28, 2021 file photo, European Commissioner for Economy Paolo Gentiloni addresses the plenary chamber at the European Parliament in Brussels. The European Union's top economy official said Monday, May 10, 2021 that the measures the EU and its 27 member states have in the works to come out of the pandemic total some US dollars 5.85 trillion. EU economy Commissioner Paolo Gentiloni told a European Parliament Committee said that if comparisons are made with U.S. President Biden pandemic stimulus relief package, the 27-nation EU can confidently stand next to to Washington when all efforts are counted together.Johanna Geron


By RAF CASERT
May 10, 2021
 Associated Press

BRUSSELS (AP) — The European Union's top economy official said Monday that the recovery measures the EU and its 27 member states have in the works to emerge from the pandemic total around $5.85 trillion.

EU Economy Commissioner Paolo Gentiloni told a European Parliament committee said that if comparisons are made with U.S. President Joe Biden's pandemic stimulus relief package, the EU can confidently stand next to to Washington when all efforts are counted together.

“Measures taken until now from member states and the EU reach so far 4.8 trillion” euros, the Italian commissioner told legislators, sweeping aside criticism that authorities weren't doing enough compared with Washington.

The EU has agreed to a common recovery fund package of 750 billion euros ($910 billion), plus a 1.1 trillion euro ($1.3 trillion) seven-year budget that will be strongly geared toward dealing with the unprecedented economic recession caused by COVID-19 that the bloc's 450 million citizens will have to overcome. Many of those measures still need a final stamp of legislative approval.

During his first 100 days in office, Biden has secured passage of a sweeping $1.9 trillion pandemic package to bring relief to 330 million Americans. There is also a proposed $2 trillion-plus infrastructure plan and the recently unveiled $1.8 trillion proposed student-families-workers plan bringing the total to a potential $6 trillion.

“If we look at it in a certain way, we could say that the U.S. reaction was stronger, faster than the European one,” Gentiloni said.

Take note, however, “that we are not a federal state. And so we have to consider both member states and the EU level,” bringing the total to $4.8 trillion.

“So we are not used to mixing all the different interventions. But if we do this, we reach an amount which is not so different from the effort of the United States,” Gentiloni said.

Many major social affairs and economic policies are still run at a national level in the European Union, and stimulus measures for companies and the workforce also have a massive national input which is rarely visible in EU statistics.

Still the 750-billion euro “Next Generation EU” package stands out because it allows the bloc for the first time to raise money on the markets by itself. Much of the aid will be spent among the poorer and harder-hit member states.

EU Vice President Valdis Dombrovskis said that if requests from member states proceeded as planned, the first disbursements to the member states on prefinancing could already be made in July. He added that the second tranches of financing could already be made before the end of the year.

The EU has a strict set of benchmarks that member states must reach if the money is to be paid out. In all, 37% must be spent on green projects, ranging from offshore wind parks to cycling tracks. And 20% must go to digital projects, including 5G networks and digitizing public administration.

Funds will only be released piecemeal once member states have proven previous aid has been spent according to plan.
‘Americans Want To Work’: Biden Says Modest Jobs Report Can’t Be Blamed On Unemployment Benefits

Like the President, Raimondo told CBS on Sunday that there is no data suggesting that Americans are out of work due to unemployment insurance, but that the fear of COVID-19 or the inability to find childcare are key reasons for why people aren’t able to go back to work.

WASHINGTON, DC - MAY 10: U.S. President Joe Biden delivers remarks on the economy in the East Room of the White House on May 10, 2021 in Washington, DC. Biden addressed criticism from Republicans after a weaker than .

By Summer Concepcion
May 10, 2021 

President Biden on Monday stressed that the slowdown of hiring nationwide last month is not an indicator that his administration’s American Rescue Plan is ineffective, and disputed the notion that unemployment insurance is hurting the job market.

Last week, the Labor Department reported that U.S. employers added a modest 266,000 jobs in April, which falls short of the one million jobs that economists forecasted and the weakest monthly gain since January, according to the Wall Street Journal.

In remarks delivered Monday, the President stated that his administration’s economic plan is working, while emphasizing that “climbing out of the deep hole” the economy found itself in amid the COVID-19 pandemic isn’t a clean-cut process.

“Some months we’ll exceed expectations, others we’ll fall short,” Biden said. “The question is: what is the trend line? Are we headed in the right direction? Are we taking the right steps to keep it going? And the answer clearly is yes.”

Biden said that monthly reports are a “snapshot” of a moment in time, before laying out the circumstances behind the Labor Department’s latest jobs report that failed to meet economists’ expectations.

The President pointed out that the jobs report was taken around the week of April 12, and that COVID-19 cases decreased by more than 40 percent and vaccination rates among working age Americans has roughly doubled since then. Biden added that the survey was taken before every adult in the country met eligibility requirements for vaccinations, with a mere 18 percent of working age adults having been fully vaccinated in time for the report’s snapshot.

“Today, if it were taken, 34 percent are fully vaccinated,” Biden said. “No wonder things in America feel better today than they did back when the survey was taken.”

Later in his remarks, Biden said that his administration will make clear that anyone collecting unemployment benefits who is offered a suitable job will be required to take the job or lose their benefits, barring a few COVID-19-related exceptions.

The President went on to hit back at the idea that the slowdown in hiring, as reflected in the latest jobs report, can be blamed on unemployment benefits.

“I know there’s been a lot of discussion since Friday’s report that people are being paid to stay home rather than go to work — we don’t see much evidence of that,” Biden said. “Look, it’s easy to say the line has been because of the generous unemployment benefits that it is a major factor in labor shortages.”

Biden insisted that “Americans want to work” and reiterated that unemployed people who are offered a job must take it or risk losing their benefits, before taking aim at the Trump administration’s disastrous response to the pandemic that led to millions of Americans losing their jobs.

“They lost their jobs to a virus and to a government that bungled its response to the crisis and failed to protect them,” Biden said. “We still have 8 million fewer jobs than we did when the pandemic started.”

The President said that unemployment benefits are a “lifeline” for Americans struggling in the pandemic, but that his administration’s work search requirements for recipients of unemployment benefits will be reinforced.

Biden’s remarks were issued a day after Commerce Secretary Gina Raimondo similarly refuted the notion that unemployment benefits are detrimental to the job market, amid Republican governors beginning to cut jobless benefits in their states, arguing that the move would force more people to return to work.

Like the President, Raimondo told CBS on Sunday that there is no data suggesting that Americans are out of work due to unemployment insurance, but that the fear of COVID-19 or the inability to find childcare are key reasons for why people aren’t able to go back to work.


 Sarah Silverman calls out Caitlyn Jenner over her ‘dumb’ views on trans athletes: ‘This is transphobia full stop’ 

 Nola Ojomu Monday 10 May 2021

 Sarah Silverman slammed Caitlyn Jenner over her recent comments about trans athletes participating in girls’ sports

Sarah Silverman claims Caitlyn Jenner is being ‘transphobic’ after the former Olympian made comments stating trans athletes born male shouldn’t play on girls’ sports teams. The comedian was one of many who hit out at the reality TV star – who came out as transgender in 2015 – after the 71-year-old made the comment during an impromptu video interview with TMZ. 

Sarah, 50, shared her thoughts about the matter on her The Sarah Silverman Podcast as she pointed out that there are multiple physical difference between cis athletes within sports. 

The Wreck-It Ralph star stated: ‘Caitlyn, you’re a woman, right? A trans girl is a girl. She should have the same rights as cis girls. ‘What, you think a trans girl is too strong? What about tall girls as opposed to short girls? What about boys in high school who are teeny tiny and their teammates have already hit puberty and are shaving?’ 

She continued: ‘Why don’t you just have co-ed sports divided by weight and height, you know? 

This is so dumb. They are legislating this s**t without one single example of how this plays out.’ 

The debate around Caitlyn’s comments comes as multiple states recently moved towards banning transgender girls and women from partaking in female sports. Florida recently passed legislation that would restrict entry to girl’s sports teams to those who were born female. 

Transgender female athletes would be limited to playing coed sports or on teams with male athletes.

 The bill applies to high school and college sports sponsored by public schools, including intramural and club teams.

 Former Olympian Caitlyn – who came out as transgender in 2015 – has doubled down on her comments despite ongoing backlash 

Sarah added: ‘This is not worrying about girls’ sports, believe me. I think there are better ways to worry about girls’ sports. ‘This is not what that is, this is not concern for girls’ sports, this is transphobia full stop. It’s just such a bummer when such a prominent trans woman is such a t**t.’

https://metro.co.uk/2021/05/10/sarah-silverman-calls-out-caitlyn-jenner-over-transphobic-comments-14553931


 

Analysis of autopsy, toxicological and psychiatric reports of Portugal's first major forensic case

Part III

COMPUSCRIPT LTD

Research News

IMAGE

IMAGE: RECOVERED PORTRAIT OF VICENTE URBINO DE FREITAS IN BRAZIL DURING HIS HEYDAY. view more 

CREDIT: FORENSIC SCIENCES RESEARCH

Analysis of The Autopsy, Toxicological, and Psychiatric Reports of Portugal's First Major Forensic Case: Part III https://doi.org/10.1080/20961790.2021.1898079

Announcing a new article publication for Forensic Sciences Research journal. In this review article the author Ricardo Jorge Dinis-Oliveira of the University Institute of Health Sciences (IUCS)-CESPU, Gandra, Portugal continues a three-part investigation of the "Crime of Flores Street" one of the most famous cases of poisoning which occurred in Portugal in the late 19th century. The case demonstrated the weaknesses of the Portuguese medicolegal system and attests to the importance of toxicological analysis. The first article retold the case which gave birth to forensic toxicology studies in Portugal and informed present day Portuguese medicolegal procedures. The second article analysed all the relevant and contradictory testimonial evidence of the prosecution and defence witnesses.

In this latest publication the author analyses the forensic evidence, particularly from the autopsy, toxicological, and psychiatric forensic reports. Today, it would be easy to perform irrefutable toxicological analysis, but in those times, the circumstantially produced evidence, together with the toxicological expert reports, allowed the court to produce a damning judgment. The author suggests, that with current knowledge, it is now possible to add further insights if the burial location of at least one victim could be identified. In late 2020 one of the victims was finally located. Permission for a new autopsy for samples collection was obtained and has been performed more than 130 years after the first major autopsy was executed in Portugal. Future research will include correlation of the identity of the victim by DNA analysis and comparison with relatives and toxicological analyses.

CAPTION

Recovered portrait of António Joaquim Ferreira da Silva.

CREDIT

Forensic Sciences Research

Related Publications

Ricardo Jorge Dinis-Oliveira, Portugal's first major forensic case and the genesis of forensic toxicology: 10 years of research to reconstruct the event, Forensic Sciences Research, 2018, ISSN 2471-1411, https://doi.org/10.1080/20961790.2018.1534538

Ricardo Jorge Dinis-Oliveira, Analysis of the testimonial evidence of Portugal's first major forensic case: part II, Forensic Sciences Research, 2019, ISSN 2471-1411, https://doi.org/10.1080/20961790.2019.1682218



Author Biography

Ricardo Jorge Dinis-Oliveira University Institute of Health Sciences (IUCS)-CESPU, and Faculty of Medicine of University of Porto, Portugal. Degree in Pharmaceutical Sciences, 2003, doctorate in Toxicology, 2007, Faculty of Pharmacy, University of Porto, Portugal. Member of Pedagogical, Scientific and Management Councils of the IUCS, member of the Installing Committee of the accreditation process of the Integrated Master in Medicine of IUCS and member of the Monitoring Committee of the 2nd and 3rd Cycles of Studies in Forensic Sciences of the University of Porto. Research interests include Toxicology and Forensic Medicine, namely in additive behaviors, fatal intoxications of pharmacological origin and others and driving under the influence of psychoactive substances. Member of Editorial Boards of several International Scientific Journals in the area of Health and Life Sciences. Author of more than 155 journal articles, 35 book chapters, 4 books and 4 national and 3 international patents. Founder and current President of the Portuguese Association of Forensic Sciences (APCF) and former Vice President of the Portuguese Society for the Study of Abuse and Neglect (SPEAN).

Article reference: Ricardo Jorge Dinis-Oliveira, Analysis of the autopsy, toxicological, and psychiatric reports of Portugal's first major forensic case: part III, Forensic Sciences Research, 2021, ISSN 2471-1411, https://doi.org/10.1080/20961790.2021.1898079

Keywords: Forensic reports; alkaloids; history of legal medicine; Flores Street; Vicente Urbino de Freitas; José António de Sampaio Junior; Mário Guilherme Augusto de Sampaio

The Journal of the Academy of Forensic Science (AFS), Shanghai, P.R. China.

Forensic Sciences Research is a quarterly peer reviewed open access, English language journal publishing international research on forensic sciences, including forensic pathology, clinical forensic medicine, criminalistics and crime scene investigation. It aims to promote forensic sciences through quality research articles, reviews, case reports, and letters to editors.

For more information, please visit https://www.tandfonline.com/toc/tfsr20/current

Editorial Board: https://www.tandfonline.com/action/journalInformation?show=editorialBoard&journalCode=tfsr20

Forensic Sciences Research is available on Taylor & Francis Online (https://www.tandfonline.com/action/showAxaArticles?journalCode=tfsr20 ).

Submissions to Forensic Sciences Research may be made using Editorial Manager® (https://www.editorialmanager.com/tfsr/default.aspx ).

Usage

187K annual downloads/views

Citation metrics

1.2 (2019) CiteScore
1.22 (2019) SNIP
0.487 (2019) SJR

Speed/acceptance

21 days avg. from submission to first decision
52 days avg. from submission to first post-review decision
53 days avg. from acceptance to online publication
31% acceptance rate

Print ISSN: 2096-1790

Online ISSN: 2471-1411

Cluster of mysterious brain disease patients baffles Canadian doctors

Alexandra Thompson
Thu, 6 May 2021

Six people are thought to have died with the mysterious disease. (Stock, Getty Images)

Doctors in Canada are somewhat baffled by a mysterious brain disease with no obvious cause.

As far back as 2013, a handful of patients have endured unexplained pain, muscle twitching and even hallucinations, to name a few symptoms.

Medics initially likened the mysterious condition to the deadly brain disorder Creutzfeldt-Jakob disease (CJD), until patient tests came back clear.

In March 2021, Radio-Canada reported medics of New Brunswick province had been warned of a cluster of patients showing signs of a disorder "not seen before".

The province is aware of 48 cases, evenly made up of men and women, aged 18 to 85. Six people are thought to have died with the disease.

Read more: Third coronavirus survivors endure psychiatric or neurological disorder within six months

Doctors believe the condition is "acquired", not genetic. With no treatment, medics are focusing on relieving a patient's discomfort ahead of further research.

While these 48 cases may be the tip of the iceberg, one medic has urged people stay calm, warning "fear paralyses".

Muscle twitching and wasting mean some patients require walking aids. (Stock, Getty Images)

One who knows the impact of this mysterious disease all too well is Roger Ellis, who collapsed on his 40th wedding anniversary two years ago following a seizure.

Healthy until that day, Ellis – who is in his early sixties – has since endured delusions and hallucinations.

Ellis – who also became unusually aggressive – was thought to be dying, however, doctors could not explain why.

Medics initially thought he may have CJD, the most famous form of which is known as mad cow disease.

Tests for CJD, along with other potential causes, have all come back clear, leaving doctors stumped.

Ellis' son Steve was listening to Radio-Canada when he heard about the public health memo.

The retired industrial mechanic is now living in a specialised care home, with his condition stable.

Read more: Stroke-like brain damage in coronavirus victims

Ellis is one of several patients under the care of Dr Alier Marrero at Dr Georges-L-Dumont University Hospital Centre, in the city of Moncton.

Dr Marrero claims medics first heard about the mysterious disease in 2015, however, one patient is thought to have developed symptoms in 2013. At the time, doctors believed it was a one-off highly-unusual case.

The majority of the 48 patients are thought to have become unwell from 2018 onwards.

They live in New Brunswick's largest city Moncton and its Acadian peninsula, which is made up of fishing communities.

The symptoms are said to be wide-ranging and vary from patient to patient.

In the early days of the illness, an individual's behaviour may change, with them becoming anxious, depressed and irritable. This may be accompanied by unexplained pain, aches and spasms.

Severe insomnia or excessive daytime sleepiness may also occur. A patient could then endure memory problems and speech defects, like stuttering or repeating words, that make it difficult to hold a conversation.

Rapid weight loss, muscle wasting, visual disturbances and co-ordination problems have also been reported.

Read more: Teacher back in classroom after being treated for brain tumour

Some patients require walking aids and wheelchairs due to severe muscle twitching.

Hallucinations have also occurred, as has temporary "Capgras delusion", when a person believes a loved one has been replaced by an imposter.

"It's quite disturbing because, for instance, a patient would tell his wife: 'Sorry ma'am you cannot get in bed, I'm a married man' and even if the wife gives her name, he'd say: 'You're not the real one,'" Dr Marrero told the BBC.

Researchers find new potential treatment for prion disease


Suspected patients are being tested for genetic diseases, as well as prions. These are a type of protein that can cause healthy proteins in a patient's brain to fold abnormally, triggering diseases like CJD.

Medics also assess whether the individual may have an autoimmune disease, cancer, an infection, heavy metals in their system or abnormal antibodies – the proteins that help fight off an infection.

As part of an investigation into the disease – led by Dr Marrero – patients are asked about their lifestyle and travel history, as well as medics uncovering any potential environmental factors or dietary sources.

"Our first common idea is there's a toxic element acquired in the environment of this patient that triggers the degenerative changes," said Dr Marrero.

One theory is chronic exposure to a so-called excitotoxin like domoic acid, which was linked to an outbreak of food poisoning from contaminated mussels in the nearby province of Prince Edward Island in 1987.

During the outbreak, a third of those affected endured memory loss, dizziness and confusion. Some fell into a coma and four died.

Researchers are also looking into the toxin beta-methylamino-L-alanine (BMAA). Produced by blue-green algae, BMAA has been linked to Alzheimer's and Parkinson's.

While it may sound alarming, cases have not been reported outside of the Acadian peninsula and Moncton.

Dr Marrero has stressed: "Work with hope not with fear, fear paralyses".
COVID-19 deaths in US are 57% higher than official reports, study suggests
A new study challenges conventional wisdom about the number of COVID-19 deaths


By MATTHEW ROZSA
PUBLISHED MAY 8, 2021 

Medical Mask On Red Background (Getty Images)

The Centers for Disease Control and Prevention (CDC) has had the unenviable task of announcing, each and every week, just how many Americans have died of COVID-19. As of Wednesday, the official tabulation was that almost 562,000 Americans had passed away with COVID-19 being cited as the cause on their death certificates. This includes more than 178,000 deaths in the first four months of 2021.

Yet one group of researchers believe that these numbers, tragic enough as they are, may actually be lower than reality.



A new study released by the University of Washington's Institute for Health Metrics and Evaluation estimated that more than 900,000 Americans have died of COVID-19 since the virus that causes it, SARS-CoV-2, entered this country a little more than a year ago. They also argued that more than 7 million people have died worldwide from the disease, more than twice as many as the official estimate of 3.24 million.

The researchers reached these conclusions by first looking at excess mortality (which the CDC defines as "the difference between the observed numbers of deaths in specific time periods and expected numbers of deaths in the same time periods") from March 2020 through May 3, 2021. After comparing those figures with what would be expected during an ordinary non-pandemic year, they adjusted the statistics to take a number of variables related to the pandemic into account. For instance, they accounted for how public health guidelines has reduced influenza infections during the pandemic era, while more people deferred their health care and might have therefore died from other ailments.

Ultimately they concluded that, effectively, all of the net extra deaths should be attributed to the SARS-CoV-2 virus because the drop in other death rates offset the additional deaths not caused by COVID-19.


"When you put all that together, we conclude that the best way, the closest estimate, for the true COVID death is still excess mortality, because some of those things are on the positive side, other factors are on the negative side," Dr. Christopher Murray, who heads the Institute for Health Metrics and Evaluation, told NPR.

An epidemiologist at Harvard University was skeptical about the IMHE study's conclusions.

"I think that the overall message of this (that deaths have been substantially undercounted and in some places more than others) is likely sound, but the absolute numbers are less so for a lot of reasons," William Hanage told NPR by email.

If the IMHE number is accurate, that would mean that roughly the same number of Americans have died of COVID-19 as died fighting in both the Civil War (498,332) and World War II (405,399). The COVID-19 pandemic has swept through the planet and left havoc in its wake, destroying economies and forcing much of the world to go into periodic stages of lockdown. The pandemic also became a big issue during the 2020 presidential election and likely played a role in why the incumbent, President Donald Trump, lost to the Democratic nominee, former Vice President Joe Biden.

MATTHEW ROZSA

Matthew Rozsa is a staff writer for Salon. He holds an MA in History from Rutgers University-Newark and is ABD in his PhD program in History at Lehigh University. His work has appeared in Mic, Quartz and MSNBC.
New antibody drug helps patients breathe; 
virus may insert genetic fragments into genetic code


FILE PHOTO: A woman holds a medical syringe and a small bottle labelled "Coronavirus COVID-19 Vaccine

Nancy Lapid Mon, 10 May 2021, 

(Reuters) - The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.

New drug helps COVID-19 patients breathe on their own

When a new monoclonal antibody drug was added to treatments being given to hospitalized COVID-19 patients who were still breathing on their own, the drug - lenzilumab from Humanigen Inc - significantly improved their odds of not needing invasive mechanical ventilation, researchers found. The 540 patients in the randomized trial were already receiving a variety of standard treatments. Half of them also received lenzilumab via three intravenous infusions. In a paper posted on Wednesday on medRxiv ahead of peer review, the research team reported that patients in the lenzilumab group had a 54% better chance of surviving without needing mechanical ventilation. In patients receiving steroids and Gilead Sciences antiviral drug remdesivir, the addition of lenzilumab improved survival without the need for mechanical ventilation by 92%. In patients under age 85 whose immune system was in the early stages of triggering a life-threatening inflammatory response, lenzilumab improved the odds of ventilator-free survival by nearly three-fold. Humanigen Chief Executive and study coauthor Dr. Cameron Durrant said his team believes the results "indicate a substantial improvement in COVID-19 treatment." (https://bit.ly/3tzY2YU)

Virus might insert genetic fragments into patients' genetic code

A controversial new paper based on laboratory experiments suggests a possible explanation for why some COVID-19 survivors still test positive on viral RNA tests months later. Small fragments of genetic instructions from the coronavirus might get integrated into infected cells' genome. In the experiments, the fragments that got inserted into the cell's genetic code came mainly from the tail-end of the viral genome and cannot induce the cell to create infectious virus. However, they might be enough to trigger a positive result on COVID-19 PCR tests. "There is no evidence that the process of these integrations into the genome causes harm," said study leader Rudolf Jaenisch of the Whitehead Institute for Biomedical Research at MIT, adding that the researchers believe that is very unlikely. Other experts have said the findings, reported on Thursday in the journal PNAS, likely reflect unintended effects of experimental methods. The researchers have so far seen the phenomenon only in test tubes. They are trying to find direct evidence for SARS-CoV-2 sequences integrated into the genome in patients, "but these experiments are technically very challenging," Jaenisch said. The vaccines from Pfizer/BioNTech BNTX.O> and Moderna use messenger RNA to teach cells to make a protein that resembles a site on the virus. But the cell quickly breaks down the RNA and gets rid of it. "There is no evidence that vaccine RNA could integrate and we believe that this is highly unlikely," Jaenisch said. The high risks of complications from COVID-19 "would be a very strong incentive to get the vaccine," he said, citing negligible risk from the shots. (https://bit.ly/3tDs9P8)

Home monitoring may keep COVID-19 patients out of hospital

A home monitoring program for patients with COVID-19 may be associated with lower odds of hospitalization, according to a new study. At the Cleveland Clinic, doctors remotely monitored 3,975 COVID-19 patients for up to 14 days after a positive test. In a study published on Thursday in JAMA Health Forum, they compared patterns of healthcare use by these patients and by 3,221 similar patients who did not participate in the program. A month after diagnosis, participants in the home monitoring program were 27% less likely than nonparticipants to have been hospitalized, although they had about a two-fold higher likelihood of outpatient visits with the home monitoring program. "As the pandemic continued and we learned more and more about the outcomes of the program, and the natural course of COVID infections in groups of patients, we were able to fine tune the program to those with highest risk," said Dr. Anita Misra-Hebert, director of the Clinic's Healthcare Delivery & Implementation Science Center. The trial was not randomized and does not provide conclusive evidence of the program's value. Instead, the researchers write, the results "support the need for randomized trials to evaluate home monitoring programs ... after COVID-19 diagnosis." (https://bit.ly/3uvHpyW; https://bit.ly/3bdJg3L)

Open https://tmsnrt.rs/3c7R3Bl in an external browser for a Reuters graphic on vaccines in development.

(Reporting by Nancy Lapid, Christine Soares and Megan Brooks; Editing by Bill Berkrot)
'Let's Do Insulin Next,' Says Ocasio-Cortez After Biden Backs IP Waiver to Boost Covid-19 Vaccine Access

"We can do it with all lifesaving pharmaceuticals," tweeted one group.


by Jessica Corbett, staff writer
Published on Wednesday, May 05, 2021
by  Common Dreams


People living with diabetes, activists, faith leaders, and healthcare advocates rallied in front of the New York Stock Exchange to commemorate World Diabetes Day as part of a National Day of Action called by the Lower Drug Prices Now Campaign on November 14, 2019 in New York City. (Photo: Erik McGregor/LightRocket via Getty Images)


After the Biden administration on Wednesday caved to global pressure and endorsed waiving intellectual property protections for Covid-19 vaccines, progressives across the United States called for taking a similar approach to other lifesaving drugs and treatments made less accessible by Big Pharma's greed.

"Let's do insulin next," tweeted Rep. Alexandria Ocasio-Cortez (D-N.Y.), a self-described "unapologetic advocate of Medicare for All" who also "believes that all people must have access to safe and affordable prescription medications."

Arizona state Sen. Martín Quezada (D-29) concurred, responding to the congresswoman: "Yes! Insulin please!"

List of reasons to not waive patent protections on insulin: https://t.co/eE65snVkP3 pic.twitter.com/AKIHM5fYHA
— RootsAction (@Roots_Action) May 5, 2021

CNBC noted Wednesday that "stocks of major pharmaceutical companies that have produced vaccines, including Moderna, BioNTech, and Pfizer, dropped sharply after news of the potential waivers first broke. Pfizer ended its trading day flat, while Moderna lost 6.1%; Johnson & Johnson shed a modest 0.4%."

Acknowledging the stock shifts, Rep. Mark Pocan (D-Wis.) tweeted, "It's almost as if Big Pharma relies on keeping lifesaving medicine inaccessible."

Reporting last year on how the U.S. patent system is a barrier to cheaper insulin, Healthline explained that "drug manufacturers have repeatedly made lots of little changes to their existing insulin products in order to apply for new patents on them."

"This process, called 'evergreening' has discouraged competitors from developing new versions of existing insulins because they'd have to chase so many changes," Healthline continued. "This has slowed down innovation, along with 'pay for delay' deals, in which insulin manufacturers pay competitors to not copy specific drugs for a period of time."


Current conditions are far from what the discoverers of insulin envisioned nearly a century ago, as Vox detailed in 2019:


When inventor Frederick Banting discovered insulin in 1923, he refused to put his name on the patent. He felt it was unethical for a doctor to profit from a discovery that would save lives. Banting's co-inventors, James Collip and Charles Best, sold the insulin patent to the University of Toronto for a mere $1. They wanted everyone who needed their medication to be able to afford it.

Today, Banting and his colleagues would be spinning in their graves: Their drug, which many of the 30 million Americans with diabetes rely on, has become the poster child for pharmaceutical price gouging.

The cost of the four most popular types of insulin has tripled over the past decade, and the out-of-pocket prescription costs patients now face have doubled. By 2016, the average price per month rose to $450—and costs continue to rise, so much so that as many as one in four people with diabetes are now skimping on or skipping lifesaving doses.

While the pharmaceutical industry on Wednesday blasted the Biden administration's decision to support a vaccine waiver, some supporters of the move noted the approach could be expanded to all lifesaving pharmaceuticals.

If we can do it with the COVID19 patent....

... we can do it with all life saving pharmaceuticals. https://t.co/LuCmwbaSU5

— Sunrise Greensboro (@SunriseGso) May 5, 2021


Abolish intellectual property protections for life-saving and quality of life-preserving/enhancing treatments and drugs.

— Walker Bragman (@WalkerBragman) May 5, 2021

"Credit where credit is due," immigrant rights advocate Erika Andiola tweeted in response to the waiver announcement. "This is the right thing to do and the Biden administration decided to do it regardless of the pressure from Big Pharma. We need more of this. Putting lives over profit."
UN committee calls on Canada to respond to claims of racist violence against Mi'kmaw fishers

Taryn Grant 
CBC TODAY

© Andrew Vaughan/The Canadian Press Mi'kmaw lawyers requested intervention from the United Nations committee on the elimination of racial discrimination.

A United Nations committee has asked Ottawa to respond to claims it didn't properly intervene in or investigate racist violence against Mi'kmaw fishers in Nova Scotia last fall.

The committee on the elimination of racial discrimination outlined its request in an April 30 letter to Leslie Norton, Canada's permanent representative to the UN in Geneva.

The committee has penned about a dozen similar letters to Canada on other matters since 2008.

Most recently, in 2020, it called for a stop to construction of three major resource projects in B.C. — the Trans Mountain pipeline expansion, Site C dam and Coastal GasLink pipeline — until affected First Nations gave their full consent.

The call was unsuccessful and work on those projects went ahead.

Nevertheless, Pam Palmater, a Mi'kmaw lawyer and one of the authors of a submission made to the UN committee requesting intervention, said she considers the committee's involvement "a significant political lever."

At a minimum, she told reporters Monday, she hopes it will compel Canada to reconsider its position on the Mi'kmaw fishery.

"We know they're not going to send an army in here and take over Canada or anything like that," Palmater said.

"It's about calling attention to both Canada and Canadians that something isn't right here, and Canada needs to come to the table in a good way."
Sipekne'katik fishery

In September, the Sipekne'katik band launched a self-regulated lobster fishery in southwest Nova Scotia to significant opposition from non-Indigenous commercial lobster fishers.

Many commercial fishers say no harvesting should happen outside the federally regulated commercial season in the area, which runs from late November to the end of May
.
© Submitted by Pam Palmater Mi'kmaw lawyer Pam Palmater is one of the authors of a request for intervention from the United Nations in Nova Scotia's longstanding lobster fishing dispute.

Mi'kmaw fishers argue they have a treaty right to fish for a "moderate livelihood" outside the federally regulated season, based on the 1999 Marshall decision from the Supreme Court of Canada.

In mid-October, the conflict reached a fever pitch with the destruction of property and hundreds of lobster caught by Mi'kmaw fishers at a pound in Middle West Pubnico, N.S. A few days later, the lobster pound was burned to the ground.
UN letter

The UN committee's letter refers to "escalating" acts of racist hate speech and violence between September and December, especially between Oct. 13 and 17, the period during which the pound was vandalized and destroyed.

The committee said it was "concerned" about allegations of a lack of response by Canadian authorities, and it set a deadline of July 14 for Canada to respond with information addressing the following:

How Canada investigated alleged acts of racism against the Mi'kmaq.

How Canada investigated an alleged lack of adequate response by authorities to those acts.

What Canada did to prevent further acts of racism against the Mi'kmaq.

What Canada did to respect, protect and guarantee fishing rights and other rights of the Mi'kmaq.


In December, Sipekne'katik Chief Mike Sack halted talks with the Department of Fisheries and Oceans after reaching an impasse over the moderate livelihood fishery.

The band is planning to launch a new self-regulated fishing season next month
USING A REALLY BIG HB PENCIL
China to draw 'separation line' on peak of Mount Everest



BEIJING — China will draw a “separation line” atop Mount Everest to prevent the coronavirus from being spread by climbers ascending Nepal's side of the mountain, Chinese state media reported Monday.

© Provided by The Canadian Press

A team of Tibetan mountaineering guides will set up the separation line at the peak before climbers attempt to reach the summit from the Chinese side, the official Xinhua News Agency said.

It was not clear what the separation line would be made of. The climbers ascending the north side of the mountain from China will be prohibited from crossing the line or coming into contact with anyone or any objects on the south, or Nepalese, side, it said.

Nepal's government and mountaineering officials did not immediately comment on the separation line.

Both countries suspended the climbing season on the world's highest mountain last year due to the pandemic. Nepal has issued permits allowing 408 foreigners to attempt climbs this year as it tries to boost tourism revenue.

China has issued permits to 38 people to climb on Mount Everest this year. Xinhua said 21 Chinese climbers were approved to attempt to reach the summit from the northern slope. A separate group of 17 climbers has also received permits to hike on the northern slope.

While China has mostly curbed domestic transmission of the virus, Nepal is experiencing a surging outbreak with record numbers of new infections and deaths in recent days. Most major cities and towns are under lockdown and all domestic and international flights are grounded.

Officials in Nepal have refused to speak about any Everest outbreak. One climber, a Norwegian, told The Associated Press last month he had developed COVID-19 and has since left the country after getting better.

Ang Tshering Sherpa, a mountaineering expert who has been in the mountaineering community for decades, said it was not possible to draw any kind of separation on the Everest summit.

The only point where climbers from both sides would even come close is the summit, which is a small space where climbers spend only a few minutes to take photographs and experience the 360-degree views.

Climbers would be wearing thick layers of clothing and gear and their faces would be covered with oxygen masks, glasses and protection from the freezing air.

“The idea that anyone with coronavirus could even reach the summit is impossible because climbers with any respiratory difficulties will just not be able to reach the altitude,” he said.

The Associated Press